Source: Eur Respir J 2014; 43: 221-232



Rating:

Share or cite this content

Citations should be made in the following way:
Hostettler Katrin E., Halter Jörg P., Gerull Sabine, Lardinois Didier, Savic Spasenija, Roth Michael, Tamm Michael. Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation. Eur Respir J 2014; 43: 221-232

Member's Comments

No comment yet.

Related content which might interest you: Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation Source: International Congress 2016 – Orphan diseases II Year: 2016 Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation Source: Eur Respir J 2011; 38: 470-472 Year: 2011 Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation Source: Annual Congress 2011 - Improving outcomes after lung transplantation Year: 2011 Dose-dependent pro- or anti-proliferative effects of calcineurin inhibitors in bronchiolitis obliterans following allogeneic stem cell transplantation Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011 Updated prevalence and risk factors for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation. Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings Year: 2018 Bronchiolitis obliterans following haematopoietic stem cell transplantation Source: Eur Respir J 2007; 29: 1007-1019 Year: 2007 Long term follow-up of patients with Bronchiolitis obliterans Syndrome after hematopoietic stem cell transplantation Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans Year: 2019 Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome Source: Eur Respir J 2008; 32: 670-677 Year: 2008 Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation Source: Eur Respir J 2004; 23: 440-445 Year: 2004 Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated? Source: Eur Respir J 2005; 25: 402-405 Year: 2005 Bronchiolitis obliterans syndrome after lung transplantation: diagnosis and treatment Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=19 Year: 2004 Home spirometry in bronchiolitis obliterans after allogeneic haematopoietic cell transplant Source: Eur Respir J, 52 (1) 1702328; 10.1183/13993003.02328-2017 Year: 2018 Bronchiolitis obliterans syndrome and bronchiolitis obliterans in lung transplantation: will a pathologist and a physician ever meet? Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=55 Year: 2004 Neutrophil mediated matrixmetalloproteinase activity is increased in bronchiolitis obliterans syndrome after lung transplantation Source: Eur Respir J 2004; 24: Suppl. 48, 179s Year: 2004 Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Source: Eur Respir J 2005; 25: 221-224 Year: 2005 A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy Source: Eur Respir J 2008; 32: 832-842 Year: 2008 Protein profiling in two different phenotypes of bronchiolitis obliterans syndrome after lung transplantation Source: Annual Congress 2010 - Mechanisms of late allograft dysfunction: new insights Year: 2010 Long term azithromycin use for bronchiolitis obliterans in ten allogeneic hematopoietic stem cell transplant recipients Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation Source: Eur Respir J 2004; 24: Suppl. 48, 177s Year: 2004 Bronchiolitis obliterans syndrome (BOS) after bone marrow transplantation (BMT) in childhood Source: Eur Respir J 2003; 22: Suppl. 45, 144s Year: 2003